Literature DB >> 19761133

Assessment of the predictivity of preoperative serum CA 125 in the differential diagnosis of uterine leiomyoma and uterine sarcoma in the Turkish female population.

N Yilmaz1, I Sahin, S Kilic, E Ozgu, T Gungor, U Bilge.   

Abstract

AIMS: Uterine leiomyomas are the most common benign tumors of the uterus. Unfortunately, the diagnostic imaging criteria for distinguishing leiomyosarcomas from leiomyomas remain vague. Our aim was to study the preoperative diagnostic value of CA 125 in the differential diagnosis of leiomyoma and uterine sarcoma.
METHODS: The subjects of the study included a total of 2,382 patients aged between 20-71 years operated for uterine myoma between the years 2005 and 2008 at our hospital, and in the same period 26 patients diagnosed with uterine sarcoma who were assessed retrospectively.
RESULTS: Assessment of the predictivity of CA 125 values in the preoperative diagnosis of uterine sarcoma showed it was not significant according to the 95% CI related to the area below the curve. The assessment of CA 125 values in the uterine sarcoma group showed that those with carcinosarcoma had higher CA 125 mean values than other sarcoma groups. The relation between staging and CA 125 in all sarcomas could not be statistically assessed.
CONCLUSION: We concluded that in the differential diagnosis of myoma and uterine sarcoma, the preoperative serum CA 125 level did not have any predictivity. Additionally, there was no association between staging and CA 125 in uterine sarcomas.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19761133

Source DB:  PubMed          Journal:  Eur J Gynaecol Oncol        ISSN: 0392-2936            Impact factor:   0.196


  8 in total

1.  CA 125 and other tumor markers in uterine leiomyomas and their association with lesion characteristics.

Authors:  Ali Babacan; Cem Kizilaslan; Ismet Gun; Murat Muhcu; Ercument Mungen; Vedat Atay
Journal:  Int J Clin Exp Med       Date:  2014-04-15

Review 2.  Circulating Transcripts and Biomarkers in Uterine Tumors: Is There a Predictive Role?

Authors:  Christine De Bruyn; Thaïs Baert; Thierry Van den Bosch; An Coosemans
Journal:  Curr Oncol Rep       Date:  2020-01-29       Impact factor: 5.075

Review 3.  Advances in the Preoperative Identification of Uterine Sarcoma.

Authors:  Junxiu Liu; Zijie Wang
Journal:  Cancers (Basel)       Date:  2022-07-20       Impact factor: 6.575

Review 4.  Preoperative Differentiation of Uterine Leiomyomas and Leiomyosarcomas: Current Possibilities and Future Directions.

Authors:  Klaudia Żak; Bartłomiej Zaremba; Alicja Rajtak; Jan Kotarski; Frédéric Amant; Marcin Bobiński
Journal:  Cancers (Basel)       Date:  2022-04-13       Impact factor: 6.575

Review 5.  Biomarkers in uterine leiomyoma.

Authors:  Gary Levy; Micah J Hill; Torie C Plowden; William H Catherino; Alicia Y Armstrong
Journal:  Fertil Steril       Date:  2012-11-29       Impact factor: 7.329

6.  Epithelioid angiosarcoma arising in a uterine leiomyoma with associated elevated CA-125: A case report.

Authors:  Sarah V Strickland; Mark R Kilgore; Elise J Simons; Mara H Rendi
Journal:  Gynecol Oncol Rep       Date:  2017-05-05

7.  Analysis of uterine corporeal mesenchymal tumors occurring after menopause.

Authors:  Yumi Ishidera; Hiroshi Yoshida; Yuka Oi; Kayo Katayama; Etsuko Miyagi; Hiroyuki Hayashi; Hiroyuki Shigeta
Journal:  BMC Womens Health       Date:  2019-01-18       Impact factor: 2.809

8.  Abdominopelvic leiomyoma with large ascites: A case report and review of the literature.

Authors:  Yi-Wei Wang; Qiong Fan; Zhao-Xia Qian; Jin-Jin Wang; Yu-Hong Li; Yu-Dong Wang
Journal:  World J Clin Cases       Date:  2021-02-26       Impact factor: 1.337

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.